Michael Jann public CV

Michael Jann, PharmD

UNT System College of Pharmacy
Professor, Pharmacotherapy

EmailMichael.Jann@unthsc.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

Dr. Jann’s research interests are in pharmacogenomics, pharmacokinetics, and pharmacodynamics of CNS and other molecules in clinical research.

Education/Academic qualification

BS in Biology, California State University Los Angeles

PharmD, University of Southern California

Fingerprint

Dive into the research topics where Michael Jann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

4929 Citations
39 h-Index
99 Article
28 Review article
12 Letter
5 Chapter
More

Do asians patients require only half of the clozapine dose prescribed for Caucasians? A critical review
Jann, M., 1 Jan 2020, In: Indian Journal of Psychological Medicine. 42, 1, p. 1-3 3 p.
Research output: Contribution to journal › Editorial

1 Scopus citations
An elective course in lesbian, gay, bisexual, and transgender health and practice issues
Jann, M. W., Penzak, S., White, A. & Tatachar, A., 2019, In: American journal of pharmaceutical education. 83, 8, p. 1723-1731 9 p., 6967.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding
Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In: Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.
Research output: Contribution to journal › Review article › peer-review
11 Scopus citations
The Evolving Role of Pharmacists in Transgender Health Care
Redfern, J. S. & Jann, M. W., 11 Apr 2019, In: Transgender Health. 4, 1, p. 118-130 13 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
4 Scopus citations
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents (CNS Drugs, (2018), 32, 3, (241-257), 10.1007/s40263-018-0508-6)
Jann, M. W. & Penzak, S. R., 1 Jun 2018, In: CNS Drugs. 32, 6, p. 603 1 p.
Research output: Contribution to journal › Comment/debate

Area of Expertise

Education/Academic qualification

Do asians patients require only half of the clozapine dose prescribed for Caucasians? A critical review

An elective course in lesbian, gay, bisexual, and transgender health and practice issues

Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding

The Evolving Role of Pharmacists in Transgender Health Care

Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents (CNS Drugs, (2018), 32, 3, (241-257), 10.1007/s40263-018-0508-6)